Want to join the conversation?
$LLL raised its 2016 net sales outlook to range of $10.15-10.25Bil from prior forecast of $9.95-10.15Bil and its EPS guidance to range of $7.65-7.85 from prior range of $7.55-7.75. $LLL still sees segment operating margin of 9.8%, net cash from operating activities of $1.03Bil, capital expenditures of $205MM and free cash flow of $825MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?